CYSTEINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Cysteine Hydrochloride patents expire, and what generic alternatives are available?
Cysteine Hydrochloride is a drug marketed by Hospira and is included in one NDA.
The generic ingredient in CYSTEINE HYDROCHLORIDE is cysteine hydrochloride. There are fourteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the cysteine hydrochloride profile page.
Summary for CYSTEINE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 214 |
| Clinical Trials: | 243 |
| Patent Applications: | 858 |
| Formulation / Manufacturing: | see details |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for CYSTEINE HYDROCHLORIDE |
| What excipients (inactive ingredients) are in CYSTEINE HYDROCHLORIDE? | CYSTEINE HYDROCHLORIDE excipients list |
| DailyMed Link: | CYSTEINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for CYSTEINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Case Comprehensive Cancer Center | Phase 2 |
| Sanjay Gandhi Postgraduate Institute of Medical Sciences | Phase 3 |
| Egymedicalpedia | N/A |
Paragraph IV (Patent) Challenges for CYSTEINE HYDROCHLORIDE
| Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
|---|---|---|---|---|---|---|
| ELCYS | Injection | cysteine hydrochloride | 500 mg/10 mL | 210660 | 1 | 2019-12-10 |
US Patents and Regulatory Information for CYSTEINE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira | CYSTEINE HYDROCHLORIDE | cysteine hydrochloride | INJECTABLE;INJECTION | 019523-001 | Oct 22, 1986 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
